Back to results
US 2026/0083672 A1Published application
Formulations and dosage amounts for administering an anti-dpp3 antibody or fragment thereof to humans
Assignee4TEEN4 Pharmaceuticals GmbH
InventorsAndreas Bergmann, Karine Bourgeois
Life of this patent
Estimating the term…
Abstract
The present inventions are directed to formulations and dosage amounts for the administration of a humanized anti-DPP3 antibody or fragment thereof to humans, including for the treatment of life-threatening circulatory failure conditions, such as shock.
Claims19
A formulation for administering an anti-DPP3 antibody or fragment thereof to a human, wherein the formulation comprises:
- (a) the anti-DPP3 antibody or fragment thereof as an active ingredient;
- (b) a stabilizer;
- (c) an antioxidant;
- and
- (d) a buffer;
- wherein the formulation is a concentrated solution suitable for intravenous administration upon dilution.
3 more elements
Dependencies are inferred from the claim text.